Pfizer

White House To Focus On Promoting COVID-19 Boosters That Target Omicron This Fall

Both Pfizer and Moderna have reportedly told the White House they can deliver doses of a new booster with updated formulations.
By 

FDA: COVID Shots Approved For Kids Under 5

FDA: COVID Shots Approved For Kids Under 5
By 

FDA Authorizes Pfizer And Moderna COVID Vaccines For Children Under 5

Shots could be in toddlers’ arms soon, pending approval from the CDC.
By 

FDA: Pfizer COVID-19 Shot Appears Effective For Kids Under 5

The review by federal health officials was a key step toward a long-awaited decision to begin vaccinating the youngest American children.
By Matthew Perrone and Mike Stobbe, AP

White House: 1st COVID-19 Shots For Kids Under 5 Possible By June 21

“At the end of the day we all want to move fast, but we’ve got to get it right," said White House COVID-19 coordinator Aashish Jha.
By ZEKE MILLER, AP

Pfizer: 3 COVID Shots Protect Young Kids

Pfizer and partner BioNTech said three COVID-19 shots protect kids under 5.
By 

Pfizer Announces Dosage Of COVID Shots For Children Under 5

Pfizer says three small doses of its COVID-19 vaccine protect kids under 5 and that it plans to give the data to U.S. regulators later this week.
By LAURAN NEERGAARD, AP

Rare Cases Of COVID Returning Pose Questions For Pfizer Pill

A small number of COVID-19 patients are relapsing after taking Pfizer's antiviral pill, raising questions about the drug at the center of the U.S. response effort.
By MATTHEW PERRONE, AP

Pfizer Hopes To Submit Little-kid Vaccine Data By Early June

Pfizer is testing three extra-small doses of its vaccine in children under 5 after two shots didn't prove quite strong enough.
By The Associated Press, AP

Pfizer To Seek COVID Booster Vaccine For Healthy 5- To 11-Year-Olds

The pharmaceutical company, in making its request, cited a small study that found that children given a booster had a 36-fold increase in virus-fighting antibodies.
By AP